Aplus Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
191
- Stock Symbol
-
6918
- Share Price
-
$2.15
- (As of Friday Closing)
Aplus General Information
Description
A Plus Biotechnology Co Ltd provides orthopedic implants and engages in the manufacturing and wholesale of medical devices such as bone material. The company's products include Chest, Shoulder, Spine, Elbow, Wrist & Hand, Pelvic & Hip, Knee, Foot & Ankle, Osteotomy, Pediatric & ESF, and Biologics. The company currently has operating segments in Taiwan and China, with the majority of revenue coming from Taiwan.
Contact Information
Website
www.aplusbio.comCorporate Office
- 3rd Floor, No. 21
- Qiaohe Road, Zhonghe District
- New Taipei City, Zhonghe District 235
- Taiwan
Corporate Office
- 3rd Floor, No. 21
- Qiaohe Road, Zhonghe District
- New Taipei City, Zhonghe District 235
- Taiwan
Aplus Stock Performance
As of 20-Nov-2026, Aplus’s stock price is $2.15. Its current market cap is $73.1M with 34.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.15 | $2.20 | $2.08 - $2.89 | $73.1M | 34.1M | 37.6K | $0.18 |
Aplus Financials Summary
As of 30-Sep-2026, Aplus has a trailing 12-month revenue of $29.1M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 69,688 | 78,806 | 67,298 | 39,909 |
| Revenue | 29,111 | 26,795 | 23,982 | 21,672 |
| EBITDA | 8,777 | 7,750 | 6,674 | 976 |
| Net Income | 6,241 | 5,430 | 4,707 | (363) |
| Total Assets | 50,899 | 49,563 | 35,802 | 34,865 |
| Total Debt | 5,175 | 3,075 | 3,248 | 3,682 |
Aplus Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aplus Comparisons
Industry
Financing
Details
Aplus Competitors (2)
One of Aplus’s 2 competitors is Medtronic, a Corporation company based in Minneapolis, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medtronic | Corporation | Minneapolis, MN | ||||
| Boston Scientific | Corporation | Marlborough, MA |
Aplus Signals
Aplus ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Aplus FAQs
-
When was Aplus founded?
Aplus was founded in 2009.
-
Where is Aplus headquartered?
Aplus is headquartered in New Taipei City, Taiwan.
-
What is the size of Aplus?
Aplus has 191 total employees.
-
What industry is Aplus in?
Aplus’s primary industry is Therapeutic Devices.
-
Is Aplus a private or public company?
Aplus is a Public company.
-
What is Aplus’s stock symbol?
The ticker symbol for Aplus is 6918.
-
What is the current stock price of Aplus?
As of 20-Nov-2026 the stock price of Aplus is $2.15.
-
What is the current market cap of Aplus?
The current market capitalization of Aplus is $73.1M.
-
What is Aplus’s current revenue?
The trailing twelve month revenue for Aplus is $29.1M.
-
Who are Aplus’s competitors?
Medtronic and Boston Scientific are competitors of Aplus.
-
What is Aplus’s annual earnings per share (EPS)?
Aplus’s EPS for 12 months was $0.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process